Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors | 2 Minute Medicine
2 Minute Medicine ,
1. There is a 71% lower risk of disease progression or death in the nirogacestat group than in the placebo group 2.
1. There is a 71% lower risk of disease progression or death in the nirogacestat group than in the placebo group 2.
Nirogacestat was found to significantly improve progression-free survival over placebo when used in the treatment of adult…